Published on: 30 November -0001
GSK consumer health, soon to be Haleon, shared that the organization has a unique opportunity to build a new company rooted first and foremost in its purpose: to deliver better everyday health to humanity. This means Haleon aims to make everyday health effective for both people and the planet with new sustainability initiatives. While building it into the DNA of the company, Katie has spent the last year embedding this purpose throughout the organization. This is how Katie explains the impact of the IRG.
“Through the IRG listening and benchmarking process, we discovered that while almost 90% of our colleagues had a clear understanding of our new purposes strategy and culture. Just 70% believed we could actually achieve this purpose. It was in this gap between understanding and believing that I found my humanizing growth opportunity, to focus our US marketing team on a path from purpose saying to purpose doing. We begin by building our purpose agenda into our commercial planning process.”
Acting on its purpose is working as the company is growing its share by more than 70% of its sales and its increasing penetration with younger and more diverse consumers.
“What I learned from the IRG100 is that purpose cannot be achieved through nature alone. As leaders, we must continue to nurture a culture that puts purpose into action”
Inspired by Katie Williams - IRG participant 2022, CMO at GSK Consumer Health / Haleon.
